temocillin has been researched along with Cystic Fibrosis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanssens, L; Sputael, V; Van Schandevyl, G | 1 |
| Gilchrist, FJ; Kitt, H; Lenney, W | 1 |
| Braun, Y; Chalhoub, H; Denis, O; Elborn, JS; Kahl, BC; Plésiat, P; Pletzer, D; Rodriguez-Villalobos, H; Tulkens, PM; Tunney, MM; Van Bambeke, F; Weingart, H; Winterhalter, M | 1 |
| Bradbury, I; Bradley, JM; Carryn, S; Döring, G; Elborn, JS; France, M; Jones, A; Kent, L; Rendall, J | 1 |
| Carryn, S; Couwenbergh, N; Tulkens, PM | 1 |
| Coenye, T; Nelis, HJ; Van Acker, H; Van Snick, E | 1 |
| Buyck, JM; Guénard, S; Plésiat, P; Tulkens, PM; Van Bambeke, F | 1 |
| Gyi, KM; Hodson, ME; Lekkas, A | 1 |
| Bingen, E; Bonacorsi, S; Fitoussi, F; Lhopital, S | 1 |
| Gaya, H; Hodson, ME; Taylor, RF | 1 |
10 other study(ies) available for temocillin and Cystic Fibrosis
| Article | Year |
|---|---|
A case report of successful eradication of new isolates of
Topics: Administration, Inhalation; Administration, Oral; Anti-Bacterial Agents; Burkholderia cenocepacia; Burkholderia Infections; Child, Preschool; Cystic Fibrosis; Humans; Levofloxacin; Male; Maxillary Sinus; Maxillary Sinusitis; Meropenem; Nasal Lavage; Otorhinolaryngologic Surgical Procedures; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
Topics: Administration, Inhalation; Adolescent; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Burkholderia cepacia complex; Burkholderia Infections; Ceftazidime; Child; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; England; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Penicillins; Tobramycin; Treatment Outcome | 2016 |
Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic.
Topics: 1-Naphthylamine; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Biological Transport; Biological Variation, Population; Cystic Fibrosis; DNA Mutational Analysis; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Penicillins; Polysaccharides, Bacterial; Porins; Pseudomonas aeruginosa; Pseudomonas Infections | 2017 |
Temocillin in cystic fibrosis: a retrospective pilot study.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Burkholderia cepacia; Burkholderia Infections; Cohort Studies; Cross-Over Studies; Cystic Fibrosis; Female; Humans; Infusions, Intravenous; Male; Penicillins; Pilot Projects; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Young Adult | 2008 |
Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patients.
Topics: Ambulatory Care; Anti-Bacterial Agents; Burkholderia Infections; Chromatography, High Pressure Liquid; Cystic Fibrosis; Drug Stability; Equipment and Supplies; Humans; Infusions, Intravenous; Penicillins; Refrigeration; Temperature; Time Factors | 2010 |
In vitro activity of temocillin against planktonic and sessile Burkholderia cepacia complex bacteria.
Topics: Anti-Bacterial Agents; Biofilms; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins | 2010 |
Role of MexAB-OprM in intrinsic resistance of Pseudomonas aeruginosa to temocillin and impact on the susceptibility of strains isolated from patients suffering from cystic fibrosis.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; Biological Transport, Active; Cystic Fibrosis; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Burkholderia cepacia; Burkholderia Infections; Cystic Fibrosis; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Lung Transplantation; Male; Middle Aged; Penicillins; Retrospective Studies; Treatment Outcome | 2006 |
Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.
Topics: Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Rifampin; Thienamycins; Tobramycin | 1999 |
Temocillin and cystic fibrosis: outcome of intravenous administration in patients infected with Pseudomonas cepacia.
Topics: Adolescent; Adult; Burkholderia cepacia; Cystic Fibrosis; Humans; Injections, Intravenous; Lung Diseases; Penicillins; Pseudomonas Infections; Sputum | 1992 |